CN105541676B - A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4 - Google Patents

A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4 Download PDF

Info

Publication number
CN105541676B
CN105541676B CN201610046370.8A CN201610046370A CN105541676B CN 105541676 B CN105541676 B CN 105541676B CN 201610046370 A CN201610046370 A CN 201610046370A CN 105541676 B CN105541676 B CN 105541676B
Authority
CN
China
Prior art keywords
bsnq
sulfoxide
cell
naphthoquinone
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610046370.8A
Other languages
Chinese (zh)
Other versions
CN105541676A (en
Inventor
金成浩
罗英花
孙虎男
臧延青
申贵男
刘畅
吴丹丹
蒋雪园
孟令旗
王浩
徐婉婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang Bayi Agricultural University
Original Assignee
Heilongjiang Bayi Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang Bayi Agricultural University filed Critical Heilongjiang Bayi Agricultural University
Priority to CN201610046370.8A priority Critical patent/CN105541676B/en
Publication of CN105541676A publication Critical patent/CN105541676A/en
Application granted granted Critical
Publication of CN105541676B publication Critical patent/CN105541676B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention discloses a kind of 2 fourth sulfoxide Isosorbide-5-Nitrae naphthoquinone compound, solve 5,8 Isosorbide-5-Nitrae naphthoquinones for not containing any substituent research it is less the problem of.The structural formula of the compound is:.The 2 fourth sulfoxide Isosorbide-5-Nitrae naphthoquinone compounds that the present invention is provided, the 5 of the compound, 8 do not contain any substituent, and 2 are replaced by sulfydryl, and 2 sulphur are oxidized to sulfoxide so that naphthoquinone compound has more superior active anticancer.

Description

A kind of 2- fourths sulfoxide -1,4- naphthoquinone compounds
Technical field
The present invention relates to a kind of new compound.
Background technology
Traditional new drug development approach is to develop and study new drug using effective components from natural materials as lead compound 's.Asian puccoon is that medicinal history is long, the extensive traditional Chinese medicine of pharmacological action, and its main pharmacodynamics composition alkannin is that have very much hair Open up the lead compound of potentiality.Alkannin has anti-inflammatory for the naphthoquinone compound of representative, antibacterial, antiviral, anti-malarial, anti-swollen A variety of physiologically actives such as knurl.Particularly in anticancer research, report that it has and suppressed growth of tumour cell, inducing cell withers Die, suppression DNA topoisomerases, suppression protein tyrosine kinase, a variety of mechanism of action such as anti-angiogenesis.Therefore, naphthoquinones class An always Many researchers class compound interested.
Research for naphthoquinone compound in recent years is concentrated mainly on the 5,8- dihydroxy 1 of 2 substitutions or 6 substitutions, 4- naphthoquinones and 5,8- dimethoxy 1,4-naphthoquinone, and the research to 5,8 1,4-naphthoquinones for not containing any substituent is fewer.
Previous research report display:The naphthaquinone derivatives of 2 sulfydryl substitutions have preferable active anticancer.And 2 sulfydryls The compound of the sulfoxide series active anticancer more superior than the series display of unoxidized sulfydryl in substituted naphthaquinone derivatives.Cause This research and design 5,8 does not contain substituent, and the naphthaquinone derivatives that 2 sulphur are oxidized to sulfoxide are necessary.
The content of the invention
The problem of in order to solve in background technology, the present invention provides a kind of new compound, 2- fourths sulfoxide -1,4-naphthoquinone.
In order to realize foregoing invention purpose, the technical solution adopted by the present invention is:A kind of 2- fourths sulfoxide -1,4- naphthoquinones chemical combination Thing,
It is characterized in that the structural formula of the compound is:
The preparation method of above-mentioned 2- fourths sulfoxide -1,4- naphthoquinone compounds is:
(1)The synthesis of 2- fourth sulfydryl -1,4- naphthoquinones
1,4-naphthoquinone and methanol are added in reaction vessel, the amount of methanol meets fully dissolving 1,4-naphthoquinone, the two The mol ratio of addition 1- butyl mercaptan after well mixed, 1- butyl mercaptan and 1,4-naphthoquinone is 1.5:1, after reacting 3-5 hours at room temperature, The mol ratio of addition sodium dichromate and the concentrated sulfuric acid into reaction vessel, sodium dichromate and 1,4-naphthoquinone is 1:5, the concentrated sulfuric acid and Isosorbide-5-Nitrae- The mol ratio of naphthoquinones is 3:4, continue to react 5-10 minutes;Then extracted with dichloromethane and saturated aqueous common salt, anhydrous sodium sulfate Dry, filtering is concentrated to dryness, obtains 2- fourths sulfydryl -1,4-naphthoquinone;
(2)The synthesis of 2- fourth sulfoxide -1,4- naphthoquinones
In reaction bulb, step is added(1)Product 2- fourths sulfydryl -1,4-naphthoquinone and chloroform, the amount of chloroform meet fully molten 2- fourths sulfydryl -1,4-naphthoquinone is solved, 3- chloroperoxybenzoic acids, 3- chloroperoxybenzoic acids and 2- fourths sulfydryl-Isosorbide-5-Nitrae-is continuously added The mol ratio of naphthoquinones is 1.2:Reacted 1.5-2.5 hours at a temperature of 1,0 DEG C, 5% NaHCO is added after reaction completely3Solution is neutralized Terminating reaction after superfluous 3- chloroperoxybenzoic acids in reaction;Reaction product is extracted through dichloromethane and saturated aqueous common salt, anhydrous Sodium sulphate is dried, filtering, is concentrated to dryness, is obtained 2- fourths sulfoxide -1,4-naphthoquinone.
Beneficial effects of the present invention:The present invention provides a kind of new 2- fourths sulfoxide -1,4-naphthoquinone compound, the compound 5,8 do not contain any substituent, and 2 are replaced by sulfydryl, and 2 sulphur are oxidized to sulfoxide so that naphthoquinone compound has There is more superior active anticancer.
Brief description of the drawings
Fig. 1 is lethal effects of the BSNQ to Hep3B cells cell.
Fig. 2 is lethal effects of the BSNQ to human hepatoma HepG2 cell.
Fig. 3 is lethal effects of the BSNQ to human liver cancer Huh7 cells.
Fig. 4 A are, with after BSNQ processing Hep3B cells, to utilize fluorescence microscope Apoptosis situation map.
Fig. 4 B are Fig. 4 A quantitative analysis figures.
Fig. 5 A are, with after BSNQ processing Hep3B cells, to utilize Apoptosis by Flow Cytometry situation map.
Fig. 5 B are Fig. 5 A quantitative analysis figures.
Fig. 6 A are, with after BSNQ processing HepG2 cells, to utilize fluorescence microscope Apoptosis situation map.
Fig. 6 B are Fig. 6 A quantitative analysis figures.
Fig. 7 A are, with after BSNQ processing Huh7 cells, to utilize fluorescence microscope Apoptosis situation map.
Fig. 7 B are Fig. 7 A quantitative analysis figures.
Embodiment
Below in conjunction with the accompanying drawings and specific embodiment the present invention is described further:
Embodiment:The preparation of 2- fourth sulfoxide -1,4- naphthoquinones
(1)The synthesis of 2- fourth sulfydryl -1,4- naphthoquinones
In 100 ml reaction bulbs, the mg of 1,4-naphthoquinone 158.15 (1 mmol) and the ml of methanol 30 is added, after being well mixed The μ l (1.5 mmol) of 1- butyl mercaptan 166 are added, after reacting 4 hours at room temperature, the mg of sodium dichromate 59.6 is added into mixture (0.2 mmol) and the μ l of the concentrated sulfuric acid 40.8 (0.75 mmol), reaction terminates after 5-10 minutes.Through dichloromethane and saturated common salt Water is extracted, appropriate anhydrous sodium sulfate drying, filtering, is concentrated to dryness, is obtained crude product, prepared through TLC, obtains 2- fourths sulfydryl-Isosorbide-5-Nitrae-naphthalene Quinone.
(2)The synthesis of 2- fourth sulfoxide -1,4- naphthoquinones(BSNQ)
In 50 ml reaction bulbs, above-mentioned product 2- fourths sulfydryl-mg of 1,4-naphthoquinone 246.32 (1mmol) and chloroform are added 20 ml, are slowly added into 3- chloroperoxybenzoic acids(MCPBA)276.1 mg (1.2 mmol), two hours are reacted at a temperature of 0 DEG C, 5% NaHCO is added after reaction completely3Solution, terminating reaction.Extracted through dichloromethane and saturated aqueous common salt, anhydrous sodium sulfate is done Dry, filtering is concentrated to dryness, obtains crude product, prepared through TLC, obtains 2- fourths sulfoxide -1,4-naphthoquinone.
Experimental example
First, lethal effects of the BSNQ to cancer cell
Experimental method:(MTT experiment)
1. inoculating cell:Individual cells suspension is made into the nutrient solution containing 10% tire calf serum, it is 10000 thin with every hole Born of the same parents are inoculated into 96 orifice plates, are 200 μ l per pore volume;
2. cell is cultivated:5% CO2, 37 DEG C are incubated 24 h, and bottom hole is paved with to cell monolayer;
3. serum starvation:Nutrient solution is changed before the h of dosing 2(Nutrient solution containing 1% FBS);
4. drug-treated:The BSNQ prepared is taken final concentration of 0,1,3,10,20,30,40,50,60 respectively, 70,80, 100 μM of processing Hep3B cells, the h of HepG2 and Huh7 cells 24;
5. color reaction:Add MTT solution per hole(5 mg/ml, are prepared with PBS, pH 7.4)20 μl.Continue to be incubated 2-4 h Afterwards, careful inhale abandons culture supernatant in hole, is carefully washed with PBS 2 times, then adds 100 μ l dimethyl sulfoxide (DMSO)s per hole(DMSO), Concussion 10 minutes, makes crystallization fully dissolve;
6. colorimetric:490 nm wavelength are selected, each hole absorbance value is determined on enzyme-linked immunosorbent assay instrument, result is recorded, with Time is abscissa, and light absorption value is that ordinate draws cell growth block diagram, as a result sees Fig. 1-Fig. 3 and table 1.
Interpretation of result:
It can be seen that BSNQ in Fig. 1-Fig. 3(IC50: 1.40 μM)All have to Hep3B cells, HepG2 and Huh7 There is good killing ability, it kills intensity and gradually risen with the increase of drug concentration.
By table 1 below it can also be seen that BSNQ(IC50: 1.40 μM)All have to Hep3B cells, HepG2 and Huh7 good Good killing ability, it kills intensity and gradually risen with the increase of drug concentration.
ICs of the BSNQ of table 1 to human liver cancer cell lethal effect50Value
2nd, apoptotic effects of the BSNQ to cancer cell
Experimental method:(Experiment in vitro-Annexin-V decoration methods)
1. inoculating cell:Individual cells suspension is made into the nutrient solution containing 10% tire calf serum, it is 10,000 thin with every hole Born of the same parents are inoculated into 12 orifice plates, are 1 ml per pore volume;
2. cell is cultivated:5% CO2,37 DEG C of 24 h of incubation, bottom hole is paved with to cell monolayer;
3. drug-treated:Add the BSNQ prepared(IC50: 1.40 μM), handle different time(0,3,6,12,24 h);
4. washed with PBS 2 times, add 195 μ l Annexin V-FITC combination liquid, add 5 μ l Annexin V- FITC is gently mixed;
5. 10 μ l propidium iodides are added(Propidium Iodide, PI)Dyeing liquor, is gently mixed;
6. room temperature(20-25℃)Lucifuge is incubated 15 minutes;
⑦(A)In the change of the form and color of fluorescence microscopy Microscopic observation cell, green fluorescence is Annexin V- FITC staining positive cells, red fluorescence is propidium iodide positive cells.Only dyed by green fluorescence, and the cell of small volume For apoptotic cell;By red or green and red double dyes, and the larger cell of volume is non-viable non-apoptotic cell;The cell not being colored is Normal cell.200 cells of random observation, try to achieve the percentage shared by various cells, and each sample counting is averaged for 3 times;
(B)Meanwhile, also detect apoptosis of the BSNQ to human liver cancer cell using Flow Cytometry methods.
1st, Hep3B cells, apoptosis of the detection BSNQ to Hep3B cells cell are handled with BSNQ
Using above-mentioned experimental method, obtained experimental result is shown in Fig. 4 A, Fig. 4 B, Fig. 5 A and Fig. 5 B, and wherein Fig. 4 A are to use After BSNQ processing Hep3B cells, using fluorescence microscope Apoptosis situation map, shikonin and 5-FU are positive right According to group;Fig. 4 B are Fig. 4 A quantitative analysis figures.Fig. 5 A are to be handled with BSNQ after Hep3B cells, thin using Flow cytometry Born of the same parents' apoptosis situation map;Fig. 5 B are Fig. 5 A quantitative analysis figures.
Interpretation of result
Use BSNQ(Final concentration of 1.40 μM)Handle after the h of Hep3B cells cell 0,3,6,12,24, carry out Annexin The double dye experiments of V-FITC/PI, and in fluorescence microscope.As can be seen that continuous with drug exposure times from Fig. 4 B Increase, Annexin V-FITC fluorescence intensities also gradually strengthen, and its Apoptosis degree is also dramatically increased.It is 24 especially when the time During h, the fluorescence intensity highest of cell.As a result illustrate, BSNQ can effectively induce the apoptosis of Hep3B cells, and in Time Dependent Property.
Use BSNQ(Final concentration of 1.40 μM)Handle after the h of Hep3B cells cell 0,3,6,12,24, carry out Annexin V-FITC and PI are marked, and pass through Apoptosis by Flow Cytometry situation.As can be seen that at medicine from Fig. 5 B The reason time is continuously increased, and the degree of liver cancer Hep3B Apoptosis is consequently increased, especially when drug exposure times reach 24 h When, the level of apoptosis of cell substantially increases.The result shows, BSNQ can effectively induce Hep3B apoptosis, and in the time according to Lai Xing.
2nd, HepG2 cells, apoptosis of the detection BSNQ to human hepatoma HepG2 cell are handled with BSNQ
Using above-mentioned experimental method, obtained experimental result is shown in that Fig. 6 A and Fig. 6 B, wherein Fig. 6 A are with BSNQ processing After HepG2 cells, using fluorescence microscope Apoptosis situation map, hikonin and 5-FU are positive controls;Fig. 6 B are The quantitative analysis figure of 6A figures.
Interpretation of result
Use BSNQ(Final concentration of 1.40 μM)Handle after the h of human hepatoma HepG2 cell 0,3,6,12,24, carry out Annexin The double dye experiments of V-FITC/PI, and in fluorescence microscope.As can be seen that continuous with drug exposure times from Fig. 6 B Increase, Annexin V-FITC fluorescence intensities also gradually strengthen, and its Apoptosis degree is also dramatically increased.It is 24 especially when the time During h, the fluorescence intensity highest of cell.BSNQ can effectively induce the apoptosis of HepG2 cells, and in time dependence.
3rd, Huh7 cells, apoptosis of the detection BSNQ to human liver cancer Huh7 cells are handled with BSNQ
Using above-mentioned experimental method, obtained experimental result is shown in that Fig. 7 A and Fig. 7 B, wherein Fig. 7 A are to handle Huh7 with BSNQ After cell, using fluorescence microscope Apoptosis situation map, shikonin and 5-FU are positive controls;Fig. 7 B are Fig. 7 A Quantitative analysis figure.
Interpretation of result
Use BSNQ(Final concentration of 1.40 μM)Handle after the h of human liver cancer Huh7 cells 0,3,6,12,24, carry out Annexin The double dye experiments of V-FITC/PI, and in fluorescence microscopy Microscopic observation.As can be seen that from Fig. 7 B with drug exposure times not Disconnected increase, Annexin V-FITC fluorescence intensities also gradually strengthen, and its Apoptosis degree is also dramatically increased.Especially it is when the time During 24 h, the fluorescence intensity highest of cell.
In summary, BSNQ(IC50: 1.40 μM)Hep3B cells, the apoptosis of HepG2 and Huh7 cells can be induced, Its cancer cell-apoptosis ability is increased over time and gradually risen.

Claims (1)

1. a kind of 2- fourths sulfoxide -1,4-naphthoquinone compound is used to prepare the application in the medicine for the treatment of liver cancer, the knot of the compound Structure formula is:
CN201610046370.8A 2016-01-25 2016-01-25 A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4 Active CN105541676B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610046370.8A CN105541676B (en) 2016-01-25 2016-01-25 A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610046370.8A CN105541676B (en) 2016-01-25 2016-01-25 A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4

Publications (2)

Publication Number Publication Date
CN105541676A CN105541676A (en) 2016-05-04
CN105541676B true CN105541676B (en) 2017-08-04

Family

ID=55821293

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610046370.8A Active CN105541676B (en) 2016-01-25 2016-01-25 A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4

Country Status (1)

Country Link
CN (1) CN105541676B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299257A (en) * 2017-10-30 2018-07-20 黑龙江八农垦大学 Ten disulfoxide of 2- -1,4-naphthoquinone compound, preparation method and using the compound as the drug of active constituent
CN107793380B (en) * 2017-10-30 2021-04-23 黑龙江八一农垦大学 2, 3-epoxy-2-propyl sulfone-5, 8-dimethoxy-1, 4-naphthoquinone, preparation method thereof and medicine containing same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1690044A (en) * 2004-04-23 2005-11-02 中国科学院上海药物研究所 5,8-menadiol diacetate derivatives and their preparing process and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101298168B1 (en) * 2008-11-21 2013-08-20 충남대학교산학협력단 Chemical inhibitor of snail―p53 binding and pharmaceutical composition for treating cancer disease comprising the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1690044A (en) * 2004-04-23 2005-11-02 中国科学院上海药物研究所 5,8-menadiol diacetate derivatives and their preparing process and use

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
2-环戊氨基-5,8-二甲氧基-1,4-萘醌抑制LPS诱导的RAW264.7细胞内ROS水平与NO的分泌;刘磊 等;《中国细胞生物学学报》;20150330;第37卷(第4期);第514-521页 *
Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells;S-H Lee 等;《Oncogene》;20100601;第29卷;第4576-4587页 *
Synthesis of a novel series of 2-alkylthio substituted naphthoquinones as potent acyl-CoA: Cholesterol acyltransferase (ACAT) inhibitors;Kyeong Lee 等;《European Journal of Medicinal Chemistry》;20130123;第62卷;第517页Scheme 2 *
新型萘醌类衍生物对细胞衰老的抑制作用;王昊乾 等;《黑龙江八一农垦大学学报》;20150831;第27卷(第4期);第72-76页 *

Also Published As

Publication number Publication date
CN105541676A (en) 2016-05-04

Similar Documents

Publication Publication Date Title
CN111303102B (en) Nitroreductase responsive hypoxic probe compound and preparation and application thereof
Kuete et al. Antimicrobial activity of the methanolic extracts and compounds from Treculia obovoidea (Moraceae)
CN105541676B (en) A kind of naphthoquinone compound of 2 fourth sulfoxide 1,4
CN105017196B (en) A kind of near-infrared ratio fluorescent probe of detection hydrazine and its application
CN105541679B (en) A kind of naphthoquinone compound of 2 pungent sulfoxide 1,4
Chithambo et al. Anti-malarial synergy of secondary metabolites from Morinda lucida Benth
Singh Phytochemical analysis of leaf callus of Bacopa monnieri L
Schunck The xanthophyll group of yellow colouring matters
Dibwe et al. Discovery of potential antiausterity agents from the Japanese cypress Chamaecyparis obtusa
CN105646300B (en) A kind of preparation method of the 2 pungent naphthoquinones of sulfoxide 1,4
CN106279002B (en) Dithiocarbonic acid derivative and its preparation method and application
Cooksey Tyrian purple from marine muricids, especially from Plicopurpura pansa (Gould, 1853)
CN107759538A (en) Naphthoquinones of 2,3 epoxy, 2 nonyl sulfone, 5,8 dimethoxy 1,4 and preparation method thereof and the medicine containing it
CN108558986A (en) Enoxolone analog derivative containing piperazine structure and preparation method thereof and purposes
CN105541678A (en) Preparation method of 2-butyl sulfoxide-1,4-naphthoquinone
CN109939097A (en) Compound is preparing the application in antiobesity agent, Bariatric agent and gene expression promotor
CN107879958B (en) 2- (4- methoxybenzene sulfydryl) -5,8- dimethoxy -1,4- naphthoquinones and preparation method thereof and drug containing it
CN107793380A (en) Naphthoquinones of 2,3 2 third sulfone of epoxy, 5,8 dimethoxy 1,4 and preparation method thereof and the medicine containing it
JP2014181233A (en) Compound separated from antrodia camphorata, extract and application of the compound and extract
CN106566276A (en) Low toxicity washing-free biological fluorescent dye, preparation method and application thereof
CN1579378A (en) Use of alkannin in preparing medicine for treating tumor disease
CN108299257A (en) Ten disulfoxide of 2- -1,4-naphthoquinone compound, preparation method and using the compound as the drug of active constituent
Chandrakala In vitro pharmacological investigations of Biophytum sensitivum callus extract: Lack of potent activities
CN107721893A (en) Naphthoquinone compound of 2 naphthalene sulfydryl, 5,8 dimethoxy 1,4 and preparation method thereof and the medicine containing it
CN103463643A (en) Preparation and application of human serum albumin-ruthenium inorganic medicine compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant